Search Results - "Groszmann, Roberto"

Refine Results
  1. 1

    Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments by Bosch, Jaume, Groszmann, Roberto J, Shah, Vijay H

    Published in Journal of hepatology (01-04-2015)
    “…Summary Among the common complication of cirrhosis portal hypertension witnessed a major improvement of prognosis during the past decades. Principally due to…”
    Get full text
    Journal Article
  2. 2

    Vascular endothelial dysfunction in cirrhosis by Iwakiri, Yasuko, Groszmann, Roberto J

    Published in Journal of hepatology (01-05-2007)
    “…Endothelial dysfunction is regarded as an early key event in multiple diseases. The assessment of vascular nitric oxide (NO) level is an indicative of…”
    Get full text
    Journal Article
  3. 3

    The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule by Iwakiri, Yasuko, Groszmann, Roberto J.

    Published in Hepatology (Baltimore, Md.) (01-02-2006)
    “…The hyperdynamic circulatory syndrome observed in chronic liver diseases is a great example of research that originated from clinical observations and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Quantitative histological-hemodynamic correlations in cirrhosis by Sethasine, Supatsri, Jain, Dhanpat, Groszmann, Roberto J., Garcia-Tsao, Guadalupe

    Published in Hepatology (Baltimore, Md.) (01-04-2012)
    “…We have previously shown, in a semiquantitative analysis of liver biopsies showing cirrhosis, that thickness of fibrous septa separating cirrhotic nodules and…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis by Berzigotti, Annalisa, Garcia‐Tsao, Guadalupe, Bosch, Jaime, Grace, Norman D., Burroughs, Andrew K., Morillas, Rosa, Escorsell, Angels, Garcia‐Pagan, Juan Carlos, Patch, David, Matloff, Daniel S., Groszmann, Roberto J.

    Published in Hepatology (Baltimore, Md.) (01-08-2011)
    “…Obesity is associated with an aggressive course in chronic viral hepatitis; however, its impact in the development of clinical decompensation (CD) in patients…”
    Get full text
    Journal Article
  11. 11

    Prevention of portal hypertension: From variceal development to clinical decompensation by Vorobioff, Julio D., Groszmann, Roberto J.

    Published in Hepatology (Baltimore, Md.) (01-01-2015)
    “…Pharmacological treatment of portal hypertension (PH) has been exclusively devoted to gastroesophageal varices–related events at different frameworks,…”
    Get full text
    Journal Article
  12. 12

    Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients by Buck, Martina, Garcia‐Tsao, Guadalupe, Groszmann, Roberto J., Stalling, Caitlin, Grace, Norman D., Burroughs, Andrew K., Patch, David, Matloff, Daniel S., Clopton, Paul, Chojkier, Mario

    Published in Hepatology (Baltimore, Md.) (01-03-2014)
    “…The rationale for screening inflammatory serum biomarkers of the hepatic vein pressure gradient (HVPG) is based on the fact that portal hypertension is…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Histological-hemodynamic correlation in cirrhosis—a histological classification of the severity of cirrhosis by Nagula, Satish, Jain, Dhanpat, Groszmann, Roberto J., Garcia-Tsao, Guadalupe

    Published in Journal of hepatology (01-01-2006)
    “…While the definitive diagnosis of cirrhosis is histological, it is the degree of portal hypertension, as determined by the hepatic venous pressure gradient…”
    Get full text
    Journal Article
  15. 15

    Nitric Oxide Synthase Generates Nitric Oxide Locally to Regulate Compartmentalized Protein S-Nitrosylation and Protein Trafficking by Iwakiri, Yasuko, Satoh, Ayano, Chatterjee, Suvro, Toomre, Derek K., Chalouni, Cecile M., Fulton, David, Groszmann, Roberto J., Shah, Vijay H., Sessa, William C.

    “…Nitric oxide (NO) is a highly diffusible and short-lived physiological messenger. Despite its diffusible nature, NO modifies thiol groups of specific cysteine…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis by Groszmann, Roberto J, Garcia-Tsao, Guadalupe, Bosch, Jaime, Grace, Norman D, Burroughs, Andrew K, Planas, Ramon, Escorsell, Angels, Garcia-Pagan, Juan Carlos, Patch, David, Matloff, Daniel S, Gao, Hong, Makuch, Robert

    Published in The New England journal of medicine (24-11-2005)
    “…Beta-blockers prevent variceal bleeding in patients with cirrhosis who already have esophageal varices. In this randomized, placebo-controlled trial, timolol…”
    Get full text
    Journal Article
  20. 20